Gustave Roussy, Cancer Campus, Grand Paris: Carcinoma, Non-Small-Cell Lung trials
The registry lists 10 Carcinoma, Non-Small-Cell Lung studies with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 6Phase 3 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung CancerRecruitingNCT07001618Phase 2
- Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12CRecruitingNCT05631249Phase 2
- Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung CancerActive, not recruitingNCT04940325Phase 2
- Atezolizumab as Induction Therapy in Non-small Cell Lung CancerCompletedNCT02994576Phase 2
- Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung CancerTerminatedNCT02679963Phase 2
- Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC PatientsCompletedNCT02040064Phase 1
- Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung CancerCompletedNCT01167530Phase 1
- Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived ExosomesCompletedNCT01159288Phase 2
- Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by SurgeryStatus unknownNCT00410683Phase 3
- Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung CancerCompletedNCT00002823Phase 3